Navigation Links
Varian Software Successfully Connected with Siemens Linear Accelerators
Date:6/13/2013

PALO ALTO, Calif., June 13, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced that clinicians at The Ohio State University (Ohio State) are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator.  The companies have developed and deployed an interface that connects Varian's ARIA® oncology information system with Siemens' ONCOR and PRIMUS accelerators and imaging systems.

"Since we launched the global strategic partnership with Siemens last year, we have been steadily working to develop software interfaces that enable clinics with Siemens linear accelerators to manage patient care using Varian software," says Kolleen Kennedy, president of Varian's Oncology Systems business.  "With this new interface, we can connect to about 80 percent of the Siemens equipment in the field.  Now the majority of Siemens-equipped sites can choose to adopt ARIA for managing all aspects of care, from initial diagnosis through post-treatment follow-up."

In March of this year, Siemens received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for connectivity between Varian's ARIA software and Siemens' ONCOR and PRIMUS linear accelerators. 

"Developing these interfaces was one of our main goals when we launched our partnership last year," says Walter Maerzendorfer, CEO of Siemens Computed Tomography and Radiation Oncology.  "We're pleased to have now released this interface and completed the first deployment at such a luminary U.S. treatment center.  We would like to thank the team at The Ohio State University for valuable clinical input during the interface development process, and for helping our teams identify ways of enhancing the workflow wh
'/>"/>

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
2. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
3. Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 ASCO Annual Meeting Shows Early Activity in Ovarian Cancer
4. Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System
5. Vermillion Supports First World Ovarian Cancer Day and Effort to Raise Awareness of the Need for Better Diagnosis and Treatment
6. Varian Enables HIPAA Compliance and Optimizes Customer Service with the Axeda Machine Cloud
7. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
8. UK Hospitals Order All Varian TrueBeam Radiotherapy Systems Offered Under Government Stimulus Program
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2013
10. Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies
11. Varian Medical Systems Spotlights Industry-Leading Motion Management and Radiosurgery Technologies at ESTRO 2013 in Geneva
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... being recalled after Health Canada tests confirmed it contains ... risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health Distribution ... the product from retail stores across Canada ... purposes, including for weight loss and increased energy. ...
(Date:12/24/2014)...  Novastem, a leader in regenerative medicine, announces ... study for ischemic stroke at Clinica Santa Clarita. ... account for 87 percent of all stroke cases. ... study, entitled "Internal Research Protocol in Combination Therapy ... and Intrathecal Administration of Neural Stem Cells in ...
(Date:12/24/2014)... DUBLIN , Dec. 24, 2014  Actavis ... that the Company has received a complete response ... (FDA) for its New Drug Application (NDA) for ... for the treatment of hypertension.   Photo ... we are disappointed in the receipt of a ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... Fla., Oct. 9 VitalRemedyMD, a physician-established company, ... improve the quality of traditional healthcare. "We are ... of Fresenius, armamentarium in helping patients with chronic ... VitalRemedyMD. A state-of-the-art medical food, VitalProteinRx is designed ...
... , ... Healthcare and HHC Nutrition Services will pay the United States $1.375 ... kickbacks and assistance under the guise of a sham durable medical ... that McKesson Corp., and its affiliate MediNet Corp. provided the kickbacks ...
Cached Medicine Technology:Fresenius Medical Care, N.A. Has Selected VitalRemedyMD's VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients 2Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services 2
(Date:12/25/2014)... (PRWEB) December 26, 2014 This is ... of the global Sterilizers industry with a focus on ... the market status of the Sterilizers manufacturers and is ... and individuals interested in the industry. This report provides ... applications and manufacturing technology. In this part, the report ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... December 25, 2014 Product liability lawsuits ... hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward ... an Order issued in the U.S. District Court, Northern ... convene an open conference on January 7, 2015, at ... Courthouse in West Palm Beach, Florida. The Conference is ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... today announced,that it has finalized an agreement with U.K.-based ... with wound dressings,manufactured by AMS., Through this collaboration, ... testing of the use of GLYC-101 with AMS, wound ... phase of testing gives rise to,favorable results, or generates ...
... Professor Ian Frazer has won the 2008 Prime Minister,s ... UQ,s Diamantina Institute for Cancer, Immunology and Metabolic Medicine, ... Rudd at a special ceremony in the Great Hall, ... , The Prime Minister,s Prize for Science is the ...
... Pa., Oct. 17 Level III Trauma,Center Accreditation ... in,Pennsylvania for the period from November 1, 2008 ... South Jackson Street, Pottsville, PA, The Pennsylvania ... by the Emergency Medical Services Act (Act 1985-45).,The ...
... Regional Expansion With Mobile Healthy,Living Experience in Greater ... of Grains brand announced today,their expansion into the ... a Mobile Healthy Living Experience at select Hannaford ... simple, better decisions,to improve their lifestyle and diet. ...
... Part of Larger Health and,Nutrition Program, HACKETTSTOWN, ... is proud to be the first confectionery company ... (GDA) nutrition labeling on,all of its chocolate, non-chocolate ... redesigned to feature new graphics on the front ...
... for Joint-Pain Sufferers Who are Confused and Concerned, About ... Reveals Truth About Makeup of Joint ... 17 A new Web site,dedicated to helping women fight ... to help joint-pain sufferers take control of,their lives with a ...
Cached Medicine News:Health News:Glycotex Finalizes Collaboration Agreement with Advanced Medical Solutions 2Health News:Glycotex Finalizes Collaboration Agreement with Advanced Medical Solutions 3Health News:PM's science prize for Ian Frazer 2Health News:Level III Trauma Center Accreditation Status for Pennsylvania 2Health News:World of Grains(TM) - The Cookie That's One Bite Better Comes to a Store Near You 2Health News:World of Grains(TM) - The Cookie That's One Bite Better Comes to a Store Near You 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 2Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 4Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 5Health News:www.Joyn7030.com, A New Web Site Dedicated to Helping Women Fight Joint Pain, Launches 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: